Form 4 for ADPT Adaptive Biotechnologies Corp
Accepted 2025-03-06 00:00:00 ET · period of report 2025-03-04 · accession 0001062993-25-004817 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-06 | 2025-03-04 | ADPT | BOBULSKY SUSAN | Chief Commercial Off, MRD | A - Grant | $0.00 | +120.0K | 373.3K | +47% | $0 |
| D | 2025-03-06 | 2025-03-05 | ADPT | BOBULSKY SUSAN | Chief Commercial Off, MRD | S - Sale | $6.98 | -26.0K | 347.2K | -7% | -$181.6K |
| D | 2025-03-06 | 2025-03-04 | ADPT | BOBULSKY SUSAN | Chief Commercial Off, MRD | A - Grant | $0.00 | +180.0K | 180.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-04 | A | A | 119,971 | $0.00 | 373,261 | D | — | — | |
| 2 | Common | Common Stock | 2025-03-05 | S | D | 26,023 | $6.98 | 347,238 | D | — | — | |
| 3 | Derivative | Stock Option (right to buy) | 2025-03-04 | A | A | 180,029 | $0.00 | 180,029 | D | $8.12 · — to 2035-03-04 | 180,029 Common Stock | (F2) The options vest with respect to 1/4 of such shares on March 4, 2026, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested. |